ASSYSTEM signs a sale agreement for its life sciences and general industry technical assistance businesses
06 Dezember 2021 - 08:35AM
ASSYSTEM signs a sale agreement for its life sciences and general
industry technical assistance businesses
Assystem signs a sale
agreement for its
life
sciences and
general
industry
technical
assistance
businesses
Paris-La Défense,
December 6,
2021,
8:35
a.m. (CET)
Assystem S.A. (ISIN: FR0000074148 - ASY) has
signed an agreement to sell its life sciences and general industry
technical assistance businesses to Expleo Group(1).
Scope of the agreement and
scheduled closing date
The agreement covers Assystem Care France,
Assystem Belgium and Assystem Care Switzerland as well as two
French going concerns (“fonds de commerce”). The revenue generated
in 2021 by these divested businesses is expected to approximate
€39 million. The enterprise value agreed between the parties
is €28 million and the deal is scheduled to close on January 1,
2022.
Adjustment of Assystem’s full-year
2021 targets due to the
application of IFRS 5
As a result of this agreement – which means that
the divested businesses will be deconsolidated as of January 1,
2021 in accordance with IFRS 5 – Assystem’s
consolidated revenue and EBITA margin(2) for full-year 2021 are now
expected to come in at around €480 million and 6.4%
respectively(3).
Also in accordance with IFRS 5, the Group
management costs that were previously allocated to the divested
businesses will be deemed to be borne by the remaining entities in
Assystem’s scope of consolidation. The estimated net effect on the
Group’s 2021 EBITA margin of deconsolidating the divested
businesses and reallocating these Group management costs is a
negative 0.2 points.
ABOUT
ASSYSTEMAssystem is an
international engineering group. As a key participant in the
industry for over 50 years, the Group supports its clients in
managing their capital expenditure throughout their asset life
cycles. Assystem S.A. is listed on Euronext Paris. To find out more
visit http://www.assystem.com / Follow Assystem on Twitter:
@Assystem
Philippe
Chevallier CFO & Deputy CEOTel.: +33 (0)1 41 25 28
07Anne-Charlotte DagornCommunications Director
acdagorn@assystem.comTel.: +33 (0)6 83 03 70 29 |
Agnès
VilleretInvestor relations -
Komodoagnes.villeret@agence-komodo.comTel.: +33 (0)6 83 28 04
15 |
(1) Expleo Group is
38.16%-owned by Assystem S.A..(2) Operating
profit before non-recurring items (EBITA) as a percentage of
revenue.(3) The Group’s full-year 2021 targets communicated on
September 15, 2021 (first-half 2021 results release available at
https://www.assystem.com/en/calendar-financial-releases/) were
previously as follows: consolidated revenue of €520 million and
EBITA margin in line with that recorded for first-half 2021 (i.e.
6.6% of revenue).
Assystem (EU:ASY)
Historical Stock Chart
Von Feb 2024 bis Mär 2024
Assystem (EU:ASY)
Historical Stock Chart
Von Mär 2023 bis Mär 2024